J Korean Acad Child Adolesc Psychiatry.
2008 Jun;19(2):61-71.
Stimulants Medication of Attention-Deficit Hyperactivity Disorder
- Affiliations
-
- 1Division of Child and Adolescent Psychiatry, Department of Neuropsychiatry, Seoul National University, College of Medicine, Seoul, Korea.
- 2Department of Psychiatry, Seoul National University College of Medicine, Bundang Hospital, Seongnam, Korea. hjyoo@snu.ac.kr
Abstract
- Attention-deficit hyperactivity disorder (ADHD) is characterized by inattention, hyperactivity, impulsiveness and problems in other higher cognitive processes such as executive function deficits. Currently, there are many treatment modalities, of which pharmacotherapy is the most strongly supported by scientific and clinical evidence. Stimulants, which are first choice in the pharmacological treatment of ADHD, block dopamine reuptake by binding the dopamine transporter and so increasing the concentration of dopamine in synaptic clefts. Stimulants are effective in improving core ADHD symptoms, as well as the nonspecific symptoms, such as aggressiveness and oppositional behavior. Frequently reported short-term adverse effects are decreased appetite, sleep disturbance, headache, dizziness and irritability. Although questions have been raised about the long-term side effects of stimulants, including growth suppression, cardiovascular events, and abuse potential, there is no clear evidence to support these concerns.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Non-Stimulant Medications in the Treatment of Attention-Deficit Hyperactivity Disorder
- Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
- Pharmacotherapy for attention-deficit/hyperactivity disorder
- Patterns and Persistence of Pharmacotherapy for Children and Adolescents with Attention Deficit Hyperactivity Disorder in South Korea
- OROS Methylphenidate Treatment of Secondary Adult ADHD after Traumatic Brain Injury
